169 related articles for article (PubMed ID: 8834197)
1. Disposition of quinapril and quinaprilat in the isolated perfused rat kidney.
Kugler AR; Olson SC; Smith DE
J Pharmacokinet Biopharm; 1995 Jun; 23(3):287-305. PubMed ID: 8834197
[TBL] [Abstract][Full Text] [Related]
2. Tubular transport mechanisms of quinapril and quinaprilat in the isolated perfused rat kidney: effect of organic anions and cations.
Kugler AR; Olson SC; Smith DE
J Pharmacokinet Biopharm; 1996 Aug; 24(4):349-68. PubMed ID: 9044165
[TBL] [Abstract][Full Text] [Related]
3. Reabsorption and metabolism of quinapril and quinaprilat in rat kidney: in vivo micropuncture studies.
Smith DE; Kugler AR; Schnermann JB
J Pharm Sci; 1995 Oct; 84(10):1147-50. PubMed ID: 8801325
[TBL] [Abstract][Full Text] [Related]
4. Determination of quinapril and quinaprilat by high-performance liquid chromatography with radiochemical detection, coupled to liquid scintillation counting spectrometry.
Kugler AR; Olson SC; Smith DE
J Chromatogr B Biomed Appl; 1995 Apr; 666(2):360-7. PubMed ID: 7633615
[TBL] [Abstract][Full Text] [Related]
5. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.
Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E
J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.
Begg EJ; Robson RA; Bailey RR; Lynn KL; Frank GJ; Olson SC
Br J Clin Pharmacol; 1990 Aug; 30(2):213-20. PubMed ID: 2144994
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.
Blum RA; Olson SC; Kohli RK; Horvath AM; Sedman AJ; Posvar EL
J Clin Pharmacol; 1990 Oct; 30(10):938-42. PubMed ID: 2229454
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients with various degrees of renal function.
Halstenson CE; Opsahl JA; Rachael K; Olson SC; Horvath AM; Abraham PA; Posvar EL
J Clin Pharmacol; 1992 Apr; 32(4):344-50. PubMed ID: 1569237
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis.
Swartz RD; Starmann B; Horvath AM; Olson SC; Posvar EL
J Clin Pharmacol; 1990 Dec; 30(12):1136-41. PubMed ID: 2273086
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure.
Begg EJ; Robson RA; Ikram H; Richards AM; Bammert-Adams JA; Olson SC; Posvar EL; Reece PA; Sedman AJ
Br J Clin Pharmacol; 1994 Mar; 37(3):302-4. PubMed ID: 8198942
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of quinapril and its active metabolite quinaprilat in human plasma using high-performance liquid chromatography with ultraviolet detection.
Abbara Ch; Aymard G; Hinh S; Diquet B
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):199-207. PubMed ID: 11824807
[TBL] [Abstract][Full Text] [Related]
12. Quinapril: a new second-generation ACE inhibitor.
Cetnarowski-Cropp AB
DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
[TBL] [Abstract][Full Text] [Related]
13. Solid-phase extraction and high-performance liquid chromatography applied to the determination of quinapril and its metabolite quinaprilat in urine.
Prieto JA; Alonso RM; Jiménez RM; Blanco A
J Chromatogr Sci; 2001 Apr; 39(4):153-9. PubMed ID: 11318067
[TBL] [Abstract][Full Text] [Related]
14. Trace analysis of quinapril and its active metabolite, quinaprilat, in human plasma and urine by gas chromatography-negative-ion chemical ionization mass spectrometry.
Goto N; Kamata T; Ikegami K
J Chromatogr; 1992 Jul; 578(2):195-201. PubMed ID: 1400797
[TBL] [Abstract][Full Text] [Related]
15. Quinapril and its metabolite quinaprilat in human milk.
Begg EJ; Robson RA; Gardiner SJ; Hudson LJ; Reece PA; Olson SC; Posvar EL; Sedman AJ
Br J Clin Pharmacol; 2001 May; 51(5):478-81. PubMed ID: 11422007
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure.
Wolter K; Fritschka E
Eur J Clin Pharmacol; 1993; 44 Suppl 1():S53-6. PubMed ID: 8387427
[TBL] [Abstract][Full Text] [Related]
17. Renal excretion mechanisms of the antiviral nucleoside analogue AM 188 in the rat isolated perfused kidney.
Wang J; Nation RL; Evans AM; Cox S
Clin Exp Pharmacol Physiol; 2004; 31(1-2):29-34. PubMed ID: 14756681
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of quinapril in children: assessment during substitution for chronic angiotensin-converting enzyme inhibitor treatment.
Blumer JL; Daniels SR; Dreyer WJ; Batisky D; Walson PD; Roman D; Ouellet D
J Clin Pharmacol; 2003 Feb; 43(2):128-32. PubMed ID: 12616664
[TBL] [Abstract][Full Text] [Related]
20. Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
Yamada S; Muraoka I; Kato K; Hiromi Y; Takasu R; Seno H; Kawahara H; Nabeshima T
Biol Pharm Bull; 2003 Jun; 26(6):872-5. PubMed ID: 12808303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
